Great Novel Therapeutics Biotech & Medicals (7427.TWO)

TWD 32.85

(-18.69%)

Market Cap (In TWD)

1.43 Billion

Revenue (In TWD)

4.85 Million

Net Income (In TWD)

-61.54 Million

Avg. Volume

204.13 Thousand

Currency
TWD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
32.05-69.9
PE
-12.88
EPS
-2.55
Beta Value
-0.014
ISIN
TW0007427007
CUSIP
-
CIK
-
Shares
43643700.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Chia-Nan Chen
Employee Count
-
Website
https://www.gntbm.com.tw
Ipo Date
2021-07-08
Details
Great Novel Therapeutics Biotech & Medicals engages in the development of drugs for the treatment of advanced and refractory cancers. It develops drugs for cancer immunotherapy, including tumor microenvironment regulators, epigenetic immunoactivators, and immune-regulating multi-kinase inhibitors. The company was formerly known as GNT Biotech & Medicals Corporation. Great Novel Therapeutics Biotech & Medicals was founded in 2013 and is based in Taipei City, Taiwan.